Research output per year
Research output per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Master in Science, Precision Medicine (Distinction, Top Student Award), The University of Manchester
Award Date: 30 Oct 2024
Postgraduate Diploma, Specialty Certificate Examination (SCE) in Medical Oncology, Royal College of Physicians
Award Date: 30 Oct 2022
Postgraduate Diploma, PGCert Postgraduate Medical Education, Edge Hill University
Award Date: 30 Jul 2022
Postgraduate Diploma, MRCP, Royal College of Physicians
Award Date: 30 Mar 2019
Bachelor of Medicine and Bachelor of Surgery, Medicine (Honours), The University of Manchester
Award Date: 30 Jun 2016
Bachelor of Science, Pharmacology (First Class), The University of Manchester
Award Date: 30 Jun 2011
External positions
Specialty Registrar in Medical Oncology, The Christie Hospital NHS Foundation Trust
5 Aug 2020 → …
Research Beacons, Institutes and Platforms
- Cancer
Fingerprint
Dive into the research topics where Roya Behrouzi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 24 Article
-
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group, 2025, (Accepted/In press) In: The Lancet Infectious Diseases.Research output: Contribution to journal › Article › peer-review
Open Access -
Cell-free and extrachromosomal DNA profiling of small cell lung cancer
Behrouzi, R., Clipson, A., Simpson, K. L., Blackhall, F., Rothwell, D. G., Dive, C. & Mouliere, F., 4 Sept 2024, (E-pub ahead of print) In: Trends in molecular medicine. 15 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group, Horby, P. W., Peto, L., Staplin, N., Campbell, M., Pessoa-Amorim, G., Mafham, M., Emberson, J. R., Stewart, R., Prudon, B., Uriel, A., Green, C. A., Dhasmana, D. J., Malein, F., Majumdar, J., Collini, P., Shurmer, J., Yates, B., Baillie, J. K. & Buch, M. H. & 14 others, , 31 Jan 2024, In: Nature Communications. 15, 1, 924.Research output: Contribution to journal › Article › peer-review
Open Access -
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group, Hughes, G., Dark, P. & Behrouzi, R., 1 Mar 2024, In: The Lancet. Child & adolescent health. 8, 3, p. 190-200 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
CDK4/6 inhibitors versus weekly paclitaxel for treatment of ER+/HER2- advanced breast cancer with impending or established visceral crisis
Behrouzi, R., Armstrong, A. C. & Howell, S. J., 1 Nov 2023, In: Breast Cancer Research and Treatment . 202, 1, p. 83-95 13 p.Research output: Contribution to journal › Article › peer-review
Open Access